Candriam SCA’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-202,674
| Closed | -$328K | – | 849 |
|
|
2023
Q1 | $328K | Buy |
+202,674
| New | +$328K | ﹤0.01% | 847 |
|
|
2020
Q4 | – | Sell |
-370,000
| Closed | -$3.5M | – | 843 |
|
|
2020
Q3 | $3.5M | Hold |
370,000
| – | – | 0.03% | 408 |
|
|
2020
Q2 | $3.32M | Sell |
370,000
-150,000
| -29% | -$1.34M | 0.04% | 405 |
|
|
2020
Q1 | $4.26M | Hold |
520,000
| – | – | 0.05% | 392 |
|
|
2019
Q4 | $4.35M | Sell |
520,000
-95,000
| -15% | -$795K | 0.05% | 404 |
|
|
2019
Q3 | $5.57M | Buy |
615,000
+200,000
| +48% | +$1.81M | 0.07% | 294 |
|
|
2019
Q2 | $4.45M | Buy |
+415,000
| New | +$4.45M | 0.06% | 357 |
|
|
2017
Q3 | – | Sell |
-160,000
| Closed | -$1.41M | – | 740 |
|
|
2017
Q2 | $1.41M | Sell |
160,000
-110,000
| -41% | -$968K | 0.03% | 525 |
|
|
2017
Q1 | $1.4M | Buy |
270,000
+70,000
| +35% | +$364K | 0.03% | 507 |
|
|
2016
Q4 | $610K | Hold |
200,000
| – | – | 0.01% | 590 |
|
|
2016
Q3 | $926K | Hold |
200,000
| – | – | 0.02% | 511 |
|
|
2016
Q2 | $1.16M | Hold |
200,000
| – | – | 0.03% | 411 |
|
|
2016
Q1 | $1.2M | Buy |
+200,000
| New | +$1.2M | 0.03% | 403 |
|
|
2015
Q1 | – | Sell |
-120,000
| Closed | -$1.83M | – | 658 |
|
|
2014
Q4 | $1.83M | Buy |
+120,000
| New | +$1.83M | 0.04% | 367 |
|